Truncated somatostatin receptor variant sst5TMD4 confers aggressive features (proliferation, invasion and reduced octreotide response) to somatotropinomasRaúl M. Luque, Justo P. Castaño, Alejandro Ibáñez‐Costa et al.|Cancer Letters|2015Cited by 91
A Cellular and Molecular Basis for the Selective Desmopressin-Induced ACTH Release in Cushing Disease Patients: Key Role of AVPR1b Receptor and Potential Therapeutic ImplicationsRaúl M. Luque, Justo P. Castaño, Alejandro Ibáñez‐Costa et al.|The Journal of Clinical Endocrinology & Metabolism|2013Cited by 81
Octreotide and pasireotide (dis)similarly inhibit pituitary tumor cells in vitroAlejandro Ibáñez‐Costa, Justo P. Castaño, Esther Rivero‐Cortés et al.|Journal of Endocrinology|2016Cited by 74
In1-ghrelin splicing variant is overexpressed in pituitary adenomas and increases their aggressive featuresAlejandro Ibáñez‐Costa, Raúl M. Luque, Manuel D. Gahete et al.|Scientific Reports|2015Cited by 60
E‐cadherin expression is associated with somatostatin analogue response in acromegalyEva Venegas‐Moreno, Alfonso Soto‐Moreno, Álvaro Flores‐Martínez et al.|Journal of Cellular and Molecular Medicine|2019Cited by 53